Sipe, Analiza S.
HRN: 09-92-06 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/09/2023
CEFUROXIME 500MG (TAB)
02/09/2023
02/16/2023
ORAL
500
BID
Ltcs
Waiting Final Action
Indication: ProphylaxisEmpirical De-escalation Type of Infection: Disseminated Systemic Infection Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes